HMGA2 is expressed during embryogenesis and is generally not or rarely expressed in adult tissues, which makes it an interesting therapeutic target since it is re-expressed in various types of human cancer, including prostate cancer [42], breast cancer [39], oesophageal cancer [49] and thyroid cancer [50]. This evidence concerns the gene HMGA2 and thyroid cancer.